结核与肺部疾病杂志 ›› 2022, Vol. 3 ›› Issue (4): 315-319.doi: 10.19983/j.issn.2096-8493.20220092
收稿日期:
2022-05-25
出版日期:
2022-08-20
发布日期:
2022-08-16
通信作者:
翟晓文
E-mail:zhaixiaowendy@163.com
Received:
2022-05-25
Online:
2022-08-20
Published:
2022-08-16
Contact:
Zhai Xiaowen
E-mail:zhaixiaowendy@163.com
摘要:
造血干细胞移植是将原始的造血干细胞移植入患者体内,实现造血细胞和免疫细胞的重建,其适应证除了血液病以外还包括原发性免疫缺陷病等先天遗传性疾病。原发性免疫缺陷病患者易发生结核病,常感染毒力弱的卡介苗和非结核分枝杆菌,可出现全身播散而威胁生命。重症联合免疫缺陷病、慢性肉芽肿病和孟德尔遗传易感分枝杆菌病是最易发生卡介苗相关并发症的原发性免疫缺陷病,可以通过造血干细胞移植获得治愈。造血干细胞移植前存在活动性结核病的患者,移植前应接受抗结核药物治疗,在原发病情允许的情况下尽可能在移植前控制结核病。造血干细胞移植受者结核病发生风险高,建议所有造血干细胞移植受者移植前行结核分枝杆菌潜伏感染筛查,阳性患者进行预防性抗结核药物治疗。
中图分类号:
钱晓文, 翟晓文. 造血干细胞移植与结核病[J]. 结核与肺部疾病杂志, 2022, 3(4): 315-319. doi: 10.19983/j.issn.2096-8493.20220092
Qian Xiaowen, Zhai Xiaowen. Hematopoietic stem cell transplantation and tuberculosis[J]. Journal of Tuberculosis and Lung Disease, 2022, 3(4): 315-319. doi: 10.19983/j.issn.2096-8493.20220092
[1] | 黄晓军. 实用造血干细胞移植. 2版. 北京: 人民卫生出版社, 2019: 3-10. |
[2] |
Bousfiha A, Jeddane L, Picard C, et al. Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification. J Clin Immunol, 2020, 40(1): 66-81. doi: 10.1007/s10875-020-00758-x.
doi: 10.1007/s10875-020-00758-x pmid: 32048120 |
[3] |
World Health Organization. BCG vaccine: WHO position paper, February 2018-Recommendations. Vaccine, 2018, 36(24): 3408-3410. doi: 10.1016/j.vaccine.2018.03.009.
doi: S0264-410X(18)30345-1 pmid: 29609965 |
[4] |
王淼, 孙炜玮, 李克莉, 等. 2015—2019年中国卡介苗疑似预防接种异常反应监测. 中国疫苗和免疫, 2021, 27(5): 594-598. doi: 10.19914/j.CJVI.2021106.
doi: 10.19914/j.CJVI.2021106 |
[5] |
Fekrvand S, Yazdani R, Olbrich P, et al. Primary Immunodeficiency Diseases and Bacillus Calmette-Guérin (BCG)-Vaccine-Derived Complications: A Systematic Review. J Allergy Clin Immunol Pract, 2020, 8(4): 1371-1386. doi: 10.1016/j.jaip.2020.01.038.
doi: S2213-2198(20)30096-9 pmid: 32006723 |
[6] |
Castagnoli R, Delmonte OM, Calzoni E, et al. Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives. Front Pediatr, 2019, 7: 295. doi: 10.3389/fped.2019.00295.
doi: 10.3389/fped.2019.00295 pmid: 31440487 |
[7] |
Gatti RA, Meuwissen HJ, Allen HD, et al. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet, 1968, 2(7583):1366-1369. doi: 10.1016/s0140-6736(68)92673-1.
doi: 10.1016/s0140-6736(68)92673-1 pmid: 4177932 |
[8] |
Rivers L, Gaspar HB. Severe combined immunodeficiency: recent developments and guidance on clinical management. Arch Dis Child, 2015, 100(7): 667-672. doi: 10.1136/archdischild-2014-306425.
doi: 10.1136/archdischild-2014-306425 pmid: 25564533 |
[9] |
Gaspar HB, Qasim W, Davies EG, et al. How I treat severe combined immunodeficiency. Blood, 2013, 122(23): 3749-3758. doi: 10.1182/blood-2013-02-380105.
doi: 10.1182/blood-2013-02-380105 pmid: 24113871 |
[10] |
Marciano BE, Huang CY, Joshi G, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol, 2014, 133(4): 1134-1141. doi: 10.1016/j.jaci.2014.02.028.
doi: 10.1016/j.jaci.2014.02.028 pmid: 24679470 |
[11] |
Pai SY, Logan BR, Griffith LM, et al.Transplantation outcomes for severe combined immunodeficiency, 2000—2009 N Engl J Med, 2014, 371(5): 434-446. doi: 10.1056/NEJMoa1401177.
doi: 10.1056/NEJMoa1401177 URL |
[12] |
Currier R, Puck JM. SCID newborn screening: What we’ve learned. J Allergy Clin Immunol, 2021, 147(2):417-426. doi: 10.1016/j.jaci.2020.10.020.
doi: 10.1016/j.jaci.2020.10.020 pmid: 33551023 |
[13] |
Gennery AR, Slatter MA, Grandin L, et al. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J Allergy Clin Immunol, 2010, 126(3): 602-610. doi: 10.1016/j.jaci.2010.06.015.
doi: 10.1016/j.jaci.2010.06.015 pmid: 20673987 |
[14] |
Haddad E, Logan BR, Griffith LM, et al. SCID genotype and 6-month posttransplant CD 4 count predict survival and immune recovery. Blood, 2018, 132(17):1737-1749. doi: 10.1182/blood-2018-03-840702.
doi: 10.1182/blood-2018-03-840702 pmid: 30154114 |
[15] |
Antoine C, Müller S, Cant A, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99 . Lancet, 2003, 316(9357):553-560. doi: 10.1016/s0140-6736(03)12513-5.
doi: 10.1016/s0140-6736(03)12513-5 |
[16] |
Fernandes JF, Rocha V, Labopin M, et al. Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood. Blood, 2012, 119(12):2949-2955. doi: 10.1182/blood-2011-06-363572.
doi: 10.1182/blood-2011-06-363572 pmid: 22308292 |
[17] |
Chiesa R, Gilmour K, Qasim W, et al. Omission of in vivo T-cell depletion promotes rapid expansion of naïve CD4+ cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant. Br J Haematol, 2012, 156(5):656-666. doi: 10.1111/j.1365-2141.2011.08994.x.
doi: 10.1111/j.1365-2141.2011.08994.x URL |
[18] |
Williams KM, Hakim FT, Gress RE. T cell immune reconstitution following lymphodepletion. Semin Immunol, 2007, 19(5):318-330. doi: 10.1016/j.smim.2007.10.004.
doi: 10.1016/j.smim.2007.10.004 pmid: 18023361 |
[19] |
Yu HH, Yang YH, Chiang BL. Chronic Granulomatous Disease: a Comprehensive Review. Clin Rev Allergy Immunol, 2021, 61(2):101-113. doi: 10.1007/s12016-020-08800-x.
doi: 10.1007/s12016-020-08800-x URL |
[20] |
Conti F, Lugo-Reyes SO, Blancas Galicia L, et al. Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases. J Allergy Clin Immunol, 2016, 138(1):241-248. doi: 10.1016/j.jaci.2015.11.041.
doi: 10.1016/j.jaci.2015.11.041 URL |
[21] |
Dunogué B, Pilmis B, Mahlaoui N, et al. Chronic Granulomatous Disease in Patients Reaching Adulthood: A Nationwide Study in France. Clin Infect Dis, 2017, 64(6):767-775. doi: 10.1093/cid/ciw837.
doi: 10.1093/cid/ciw837 URL |
[22] |
Cole T, Pearce MS, Cant AJ, et al. Clinical outcome in children with chronic granulomatous disease managed conservatively or with hematopoietic stem cell transplantation. J Allergy Clin Immunol, 2013, 132(5): 1150-1155. doi: 10.1016/j.jaci.2013.05.031.
doi: 10.1016/j.jaci.2013.05.031 URL |
[23] |
Güngör T, Teira P, Slatter M, et al. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet, 2014, 383(9915):436-448. doi: 10.1016/S0140-6736(13)62069-3.
doi: 10.1016/S0140-6736(13)62069-3 URL |
[24] |
Morillo-Gutierrez B, Beier R, Rao K, et al. Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience. Blood, 2016, 128(3):440-448. doi: 10.1182/blood-2016-03-704015.
doi: 10.1182/blood-2016-03-704015 pmid: 27216217 |
[25] |
Jouanguy E, Altare F, Lamhamedi S, et al. Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. New Engl J Med, 1996, 335(26): 1956-1961. doi: 10.1056/NEJM199612263352604.
doi: 10.1056/NEJM199612263352604 pmid: 8960475 |
[26] |
Das J, Banday AZ, Shandilya J, et al. An updated review on Mendelian susceptibility to mycobacterial diseases-a silver jubilee celebration of its first genetic diagnosis. Expert Rev Clin Immunol, 2021, 17(10): 1103-1120. doi: 10.1080/1744666X.2021.1956314.
doi: 10.1080/1744666X.2021.1956314 URL |
[27] |
Bustamante J, Boisson-Dupuis S, Abel L, et al. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity. Semin Immunol, 2014, 26(6):454-470. doi: 10.1016/j.smim.2014.09.008.
doi: 10.1016/j.smim.2014.09.008 pmid: 25453225 |
[28] |
Bax HI, Freeman AF, Ding L, et al. Interferon alpha treatment of patients with impaired interferon gamma signaling. J Clin Immunol, 2013, 33(5):991-1001. doi: 10.1007/s10875-013-9882-5.
doi: 10.1007/s10875-013-9882-5 pmid: 23512243 |
[29] |
Olbrich P, Martínez-Saavedra MT, Perez-Hurtado JM, et al.Diagnostic and therapeutic challenges in a child with complete Interferon-γ Receptor 1 deficiency Pediatr Blood Cancer, 2015, 62(11):2036-2039. doi: 10.1002/pbc.25625.
doi: 10.1002/pbc.25625 pmid: 26173802 |
[30] |
Moilanen P, Korppi M, Hovi L, et al. Successful hematopoietic stem cell transplantation from an unrelated donor in a child with interferon gamma receptor deficiency. Pediatr Infect Dis J, 2009, 28(7):658-660. doi: 10.1097/INF.0b013e318195092e.
doi: 10.1097/INF.0b013e318195092e pmid: 19451859 |
[31] |
Zerbe CS, Dimitrova D, Gea-Banacloche JJ, et al. Successful Matched Related Bone Marrow Transplantation in a Patient with Autosomal Dominant Interferon Gamma Receptor 1 Deficiency. J Clin Immunol, 2020, 40(7):1045-1047. doi: 10.1007/s10875-020-00826-2.
doi: 10.1007/s10875-020-00826-2 URL |
[32] |
Mamishi S, Pourakbari B, Moradzadeh M, et al. Prevalence of active tuberculosis infection in transplant recipients: A systematic review and meta-analysis. Microb Pathog, 2020, 139:103894. doi: 10.1016/j.micpath.2019.103894.
doi: 10.1016/j.micpath.2019.103894 URL |
[33] | World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva:World Health Organization, 2018. |
[34] |
de Oliveira Rodrigues M, de Almeida Testa LH, Dos Santos ACF, et al. Latent and active tuberculosis infection in allogeneic hematopoietic stem cell transplant recipients: a prospective cohort study. Bone Marrow Transplant, 2021, 56(9): 2241-2247. doi: 10.1038/s41409-021-01329-3.
doi: 10.1038/s41409-021-01329-3 URL |
[35] |
Kimberlin D, Brady M, Jackson M. Red Book: 2018—2021 Report of the Committee on Infectious Diseases. 31st Ed. Itasca:American Academy of Pediatrics, 2018:829-853. doi: 10.1542/9781610021470.
doi: 10.1542/9781610021470 |
[36] |
Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant, 2009, 15(10):1143-1238. doi: 10.1016/j.bbmt.2009.06.019.
doi: 10.1016/j.bbmt.2009.06.019 URL |
[37] |
Sester M, van Leth F, Bruchfeld J, et al. Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. Am J Respir Crit Care Med, 2014, 190(10):1168-1176. doi: 10.1164/rccm.201405-0967OC.
doi: 10.1164/rccm.201405-0967OC URL |
[38] |
Lee YM, Lee SO, Choi SH, et al. A prospective longitudinal study evaluating the usefulness of the interferon-gamma releasing assay for predicting active tuberculosis in allogeneic hematopoietic stem cell transplant recipients. J Infect, 2014, 69(2):165-173. doi: 10.1016/j.jinf.2014.02.019.
doi: 10.1016/j.jinf.2014.02.019 URL |
[39] |
中华医学会结核病学分会, 中国防痨协会学校与儿童结核病防治专业分会. 卡介苗不良反应临床处理指南. 中国防痨杂志, 2021, 43(6): 532-538. doi: 10.3969/j.issn.1000-6621.2021.06.002.
doi: 10.3969/j.issn.1000-6621.2021.06.002 |
[40] |
Bumbacea D, Arend SM, Eyuboglu F, et al. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J, 2012, 40(4):990-1013. doi: 10.1183/09031936.00000712.
doi: 10.1183/09031936.00000712 pmid: 22496318 |
[41] |
Marciano BE, Huang CY, Joshi G, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol, 2014, 133(4): 1134-1141. doi: 10.1016/j.jaci.2014.02.028.
doi: 10.1016/j.jaci.2014.02.028 pmid: 24679470 |
[1] | 陈禹, 李晓睿, 王妙然, 张雨颀, 刘畅, 王照华, 石杰, 樊丽超, 尹智华, 谢建平. 金属离子在结核病中的作用研究进展[J]. 结核与肺部疾病杂志, 2025, 6(1): 102-112. |
[2] | 徐雁南, 方梓昊, 赵文丽, 郑佳雄, 刘苏洋, 林健雄, 纪丽微, 常巧呈. 中国异烟肼耐药结核分枝杆菌基因突变特征分析[J]. 结核与肺部疾病杂志, 2025, 6(1): 14-21. |
[3] | 万莹, 庞学文, 张帆. 2010—2020年天津市结核病防治健康促进工作效果评价[J]. 结核与肺部疾病杂志, 2025, 6(1): 22-29. |
[4] | 赵永年, 张丽杰, 王童敏. 2014—2023年新疆生产建设兵团肺结核报告发病流行病学特征分析[J]. 结核与肺部疾病杂志, 2025, 6(1): 30-34. |
[5] | 郑建莉, 吴语媚, 张仕利, 杜恣闲, 李土荣, 陈石生, 林文革. 福建省龙岩市结核病重点高危人群主动筛查成本效果分析[J]. 结核与肺部疾病杂志, 2025, 6(1): 35-39. |
[6] | 杨艳, 董文, 陈建军, 张玉. 2014—2023年湖北省十堰市竹溪县肺结核流行特征分析[J]. 结核与肺部疾病杂志, 2025, 6(1): 40-45. |
[7] | 齐威, 赵恩奕. 2006—2020年天津市中心城区老年与非老年肺结核流行特征及变化趋势[J]. 结核与肺部疾病杂志, 2025, 6(1): 46-54. |
[8] | 阎庆虎, 薛峰, 于泳, 秦毅, 阎庆梅, 崔嘉. 超声引导下微波消融技术在局限性结核病变治疗中的价值分析[J]. 结核与肺部疾病杂志, 2025, 6(1): 55-60. |
[9] | 陈静, 秦娅莉, 王明栋, 杨儒斌, 王倩, 彭燕清, 邱继瑶, 张晓, 周昕艾. QuantiFERON-TB Gold Plus检测活动性肺结核的效能分析[J]. 结核与肺部疾病杂志, 2025, 6(1): 61-67. |
[10] | 顾金花, 张盼盼. 三种结核分枝杆菌检测方法在某综合医院的应用价值评估[J]. 结核与肺部疾病杂志, 2025, 6(1): 68-72. |
[11] | 闫文华, 陈文君. 数智化健康教育在菌阳肺结核患者陪护者预防管理中的价值[J]. 结核与肺部疾病杂志, 2025, 6(1): 73-78. |
[12] | 廖影, 庞艳, 赵静, 何高琴, 游茂林, 王蕾. 2018—2023年重庆市梁平区肺结核患者报告情况及发现延迟特征分析[J]. 结核与肺部疾病杂志, 2025, 6(1): 8-13. |
[13] | 张莹, 郭春辉. 结核性气管支气管狭窄的治疗研究进展[J]. 结核与肺部疾病杂志, 2025, 6(1): 87-93. |
[14] | 杨舒琪, 李锋. 程序性死亡受体1/程序性死亡-配体1抑制剂在结核病研究中的进展[J]. 结核与肺部疾病杂志, 2025, 6(1): 94-101. |
[15] | 欧庆芬. 非结核分枝杆菌肺病的CT诊断及鉴别诊断[J]. 结核与肺部疾病杂志, 2024, 5(S): 13-14. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||